BackBlackRock Health Sciences Term Trust Overview
BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust Return on Equity

Latest ROE for BlackRock Health Sciences Term Trust: 5.66% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

5.66%

Return on Equity

5.66%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

BlackRock Health Sciences Term Trust (BMEZ) FAQ

The latest ROE for BMEZ is 5.66%. That is above the sector sector average of -5.72%. Investors often review this figure alongside BlackRock Health Sciences Term Trust's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BMEZ currently prints 5.66% for ROE, while the sector average sits near -5.72%. That is roughly 198.8% above the sector mean. Large gaps often invite a closer look at BlackRock Health Sciences Term Trust's growth, margins, and balance sheet.

Return on Equity shows how effectively BlackRock Health Sciences Term Trust converts resources into returns. At 5.66%, BMEZ may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BMEZ's ROE (5.66%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.